Axial Therapeutics Announces Age Expansion in Global Phase 2b Clinical Trial for Irritability Associated with Autism Spectrum Disorder (ASD)
April 04, 2023 08:00 ET
|
Axial Therapeutics
-- Children aged 5 to 17 with autism are now eligible to enroll in the clinical trial of AB-2004, a gut targeted, molecular therapeutic -- -- Novel small molecule microbiome approach focused on...
Axial Therapeutics Announces Key Research and Development Promotions to Advance Clinical and Preclinical Pipeline of Small Molecule Microbiome Therapeutics
March 29, 2023 08:00 ET
|
Axial Therapeutics
– Phase 2b clinical trial for AB-2004 in autism irritability ongoing and enrollment anticipated to be complete by end of 2023 – – IND-enabling studies ongoing for Parkinson’s Disease development...
STEP Thrift Store and Donation Centers Implements CentralReach’s avail® Software Organization-Wide to Hire, Train, and Retain Neurodiverse Employees
March 28, 2023 10:00 ET
|
CentralReach
Fort Lauderdale, Fla., March 28, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of autism and IDD care software, today announced that Services To Enhance Potential (STEP) Thrift Store...
New Study: Brain Training Improve Clinical and Cognitive Measures in Autism
March 27, 2023 08:00 ET
|
Posit Science
SAN FRANCISCO, March 27, 2023 (GLOBE NEWSWIRE) -- New results from a study of brain training among people with autism spectrum disorder (ASD) show significant gains in clinical and cognitive...
Coming Off a Strong 2022, CentralReach Enters 2023 with a Focus on Helping Customers Unlock Positive Financial and Clinical Outcomes as They Navigate Current Economic Conditions and Staffing Challenges
March 21, 2023 11:00 ET
|
CentralReach
Fort Lauderdale, Fla., March 21, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD Care software, today announced a positive momentum for 2023 with a focus on helping...
PaxMedica Holds Meeting of Scientific Advisory Board
March 20, 2023 08:00 ET
|
PaxMedica, Inc.
Board Includes Several Key Opinion Leaders on Autism Spectrum Disorder in U.S. TARRYTOWN, NY, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical...
Little Leaves Behavioral Services Announces the Opening of Its Newest Location in Frederick, Maryland
March 13, 2023 08:38 ET
|
Little Leaves
FREDERICK, Md., March 13, 2023 (GLOBE NEWSWIRE) -- Little Leaves Behavioral Services, a leading provider of center-based behavioral health services for preschool-aged children on the autism...
Bierman Autism Centers Celebrates Trademark for their Inspiring Tagline: Success as Unique as Our Kids™.
March 08, 2023 05:00 ET
|
Bierman Autism Centers
Indianapolis, Ind., March 08, 2023 (GLOBE NEWSWIRE) -- Bierman Autism Centers (Bierman) proudly announces that they have secured the trademark for its tagline, Success as Unique as Our Kids™,...
SciSparc Signs Agreement for the Supply of CBD-rich Cannabis Oil for its Clinical Trial on Children with Autism Spectrum Disorder
February 27, 2023 09:11 ET
|
SciSparc Ltd
The cannabis oil will be used as a part of the Company's proprietary SCI-210 treatment combination of CBD and CannAmide™ TEL AVIV, Israel, Feb. 27, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
CentralReach Named a Top Place to Work in South Florida for the Third Consecutive Year
February 24, 2023 10:00 ET
|
CentralReach
Fort Lauderdale, Fla., Feb. 24, 2023 (GLOBE NEWSWIRE) -- CentralReach, the leading provider of Autism and IDD Care software, has been named one of the best places to work in South Florida by the...